BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 15606616)

  • 1. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF mice.
    Nozaki Y; Yamagata T; Yoo BS; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M; Kanamaru A
    Clin Exp Immunol; 2005 Jan; 139(1):74-83. PubMed ID: 15606616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effect of all-trans-retinoic acid in inflammatory arthritis.
    Nozaki Y; Yamagata T; Sugiyama M; Ikoma S; Kinoshita K; Funauchi M
    Clin Immunol; 2006 Jun; 119(3):272-9. PubMed ID: 16412693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin prevents the development of nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Yung S; Tsang R; Zhang F; Chan KW; Tam S; Chan TM
    Lupus; 2008 Apr; 17(4):305-13. PubMed ID: 18413412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
    Enghard P; Langnickel D; Riemekasten G
    Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice.
    Kinoshita K; Yoo BS; Nozaki Y; Sugiyama M; Ikoma S; Ohno M; Funauchi M; Kanamaru A
    J Immunol; 2003 Jun; 170(11):5793-8. PubMed ID: 12759464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
    Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
    J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
    Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
    Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis.
    Liao W; Zheng H; Wu S; Zhang Y; Wang W; Zhang Z; Zhou C; Wu H; Min J
    Am J Nephrol; 2017; 46(5):371-379. PubMed ID: 29069649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapamycin attenuates the severity of established nephritis in lupus-prone NZB/W F1 mice.
    Lui SL; Tsang R; Chan KW; Zhang F; Tam S; Yung S; Chan TM
    Nephrol Dial Transplant; 2008 Sep; 23(9):2768-76. PubMed ID: 18445640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
    Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
    Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptor for advanced glycation end products alleviates nephritis in (NZB/NZW)F1 mice.
    Lee SW; Park KH; Park S; Kim JH; Hong SY; Lee SK; Choi D; Park YB
    Arthritis Rheum; 2013 Jul; 65(7):1902-12. PubMed ID: 23553192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
    Suwannaroj S; Lagoo A; McMurray RW
    Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of lupus-prone NZB/NZW F1 mice with recombinant soluble Fc gamma receptor II (CD32).
    Werwitzke S; Trick D; Sondermann P; Kamino K; Schlegelberger B; Kniesch K; Tiede A; Jacob U; Schmidt RE; Witte T
    Ann Rheum Dis; 2008 Feb; 67(2):154-61. PubMed ID: 17557887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasma gondii infection inhibits the development of lupus-like syndrome in autoimmune (New Zealand Black x New Zealand White) F1 mice.
    Chen M; Aosai F; Norose K; Mun HS; Ishikura H; Hirose S; Piao LX; Fang H; Yano A
    Int Immunol; 2004 Jul; 16(7):937-46. PubMed ID: 15148287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roquinimex-mediated protection effect on the development of chronic graft-versus-host disease in mice is associated with induction of Th1 cytokine production and inhibition of proinflammatory cytokine production.
    Xiao ZY; Zhou WX; Zhang YX; Cheng JP; He JF; Yang RF; Yun LH
    Life Sci; 2007 Oct; 81(19-20):1403-10. PubMed ID: 17950363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
    Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
    Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sophorae radix reduces autoimmune response in NZB/w F1 systemic lupus erythematosus mouse model.
    Ko E; Lee Y; Park N; Cho C; Yim YN; Kim J; Kim YS; Kim D; Shin MK; Hong MC; Bae H
    Lupus; 2007; 16(5):335-41. PubMed ID: 17576735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease.
    Zoja C; Corna D; Benedetti G; Morigi M; Donadelli R; Guglielmotti A; Pinza M; Bertani T; Remuzzi G
    Kidney Int; 1998 Mar; 53(3):726-34. PubMed ID: 9507220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis.
    Zoja C; Benigni A; Noris M; Corna D; Casiraghi F; Pagnoncelli M; Rottoli D; Abbate M; Remuzzi G
    Kidney Int; 2001 Aug; 60(2):653-63. PubMed ID: 11473648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies from long-lived 'memory' plasma cells of NZB/W mice drive immune complex nephritis.
    Cheng Q; Mumtaz IM; Khodadadi L; Radbruch A; Hoyer BF; Hiepe F
    Ann Rheum Dis; 2013 Dec; 72(12):2011-7. PubMed ID: 24114925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.